Geographic Mapping of Escherichia coli Susceptibility To Develop a Novel Clinical Decision Support Tool

Antimicrobial resistance (AMR) varies regionally. This study longitudinally maps susceptibility leveraging Wisconsin antibiograms (  = 202) collected from 2009, 2013, and 2015 to inform the development of a novel clinical decision support tool. Spatial interpolation methods were tested with suscepti...

Full description

Saved in:
Bibliographic Details
Published in:Antimicrobial agents and chemotherapy 2019-06, Vol.63 (6)
Main Authors: Legenza, Laurel, Barnett, Susanne, Lacy, James P, See, Codie, Desotell, Natalee, Eibergen, Andrea, Piccirillo, Jeffrey F, Rose, Warren E
Format: Article
Language:English
Subjects:
Anti-Bacterial Agents
Anti-Bacterial Agents - pharmacology
Antimicrobial Stewardship
Decision Support Systems, Clinical
Drug Resistance, Bacterial
Epidemiology and Surveillance
Escherichia coli
Escherichia coli - drug effects
Escherichia coli Infections
Escherichia coli Infections - drug therapy
Escherichia coli Infections - epidemiology
Escherichia coli Infections - microbiology
Geographic Mapping
Humans
Microbial Sensitivity Tests
Wisconsin - epidemiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Antimicrobial resistance (AMR) varies regionally. This study longitudinally maps susceptibility leveraging Wisconsin antibiograms (  = 202) collected from 2009, 2013, and 2015 to inform the development of a novel clinical decision support tool. Spatial interpolation methods were tested with susceptibilities to create geographic AMR visualizations and to estimate susceptibility in areas without AMR data. These visualizations and an interactive mapping tool, the AMR Tracker, provide a proof of concept for empirical antibiotic treatment decisions.
ISSN:0066-4804
1098-6596
DOI:10.1128/AAC.00048-19